Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) has announced that it will push forward with a midstage trial in the treatment of COVID-19.
Thursday's top analyst upgrades and downgrades included Costco, Enphase Energy, Etsy, Moderna, Novavax, Regeneron Pharmaceuticals, Roku, Square, Teva Pharmaceutical, Wayfair and Zynga.
Credit Suisse has identified some of its favorite Outperform-rated stocks among the integrated and regulated utilities.
Here are five biotech stocks that are rated Buy by the Jefferies analysts, are trading under the $10 level and could provide investors with some solid upside potential.
While they are more suited for aggressive accounts, these three biotech stocks trading under $10 that could provide investors with some solid upside potential.
The top analyst upgrades, downgrades and initiations seen on Monday include AK Steel, Bloom Energy, Chipotle Mexican Grill, CIT, Cushman & Wakefield, Foot Locker, Sonos and U.S. Steel.
La Jolla Pharmaceutical and Sarepta Therapeutics are among seven biotech stocks that have seen some notable insider trading recently.
Here are five stocks to consider for aggressive accounts that look to get share-count leverage on companies that have sizable upside potential.
We screened our 24/7 Wall St. research database and found five stocks trading under the $10 levels that could provide investors with some solid upside potential.
These five stocks trading under the $10 level could prove to be exciting additions to portfolios looking for solid alpha potential.
Rigel Pharmaceuticals shares retreated early Wednesday despite an approval from the FDA for its treatment of thrombocytopenia.
Rigel Pharmaceuticals saw its shares pull back early on Tuesday after the firm announced topline data from a midstage study.
While there is no guarantee that these four biotech companies are acquired, they are outstanding stocks to own in aggressive growth portfolios on their own.
Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock moves. Some stocks have the potential to double or even crater, should a study be...
The top analyst upgrades, downgrades and other research calls from Monday include Apple, Broadcom, CarGurus, Cree, Rigel Pharmaceuticals, T-Mobile, Sprint, Twitter and Weatherford.